Cargando…
Sofosbuvir and ledipasvir decreased nephrotic syndrome caused by IgA nephropathy with a membranoproliferative pattern of injury in hepatitis C virus-induced cirrhosis: a case report
BACKGROUND: Immunoglobulin (Ig) A nephropathy (IgAN) with a membranoproliferative pattern of injury that manifests as nephrotic syndrome (NS) is rarely reported in hepatitis C virus (HCV)-induced cirrhosis. It is not known whether eradication of HCV by direct-acting antiviral (DAA) drugs can lead to...
Autores principales: | Zhang, Xiaohao, Zhou, Jing, Li, Canming, Rao, Jialing, Li, Yuanqing, Zhang, Jun, Peng, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9096367/ https://www.ncbi.nlm.nih.gov/pubmed/35571427 http://dx.doi.org/10.21037/atm-21-5289 |
Ejemplares similares
-
IgA Nephropathy with Pathologic Features of Membranoproliferative Glomerulonephritis following Burn Injury
por: Zhu, Jili, et al.
Publicado: (2014) -
Decreasing racial disparity with the combination of ledipasvir–sofosbuvir for the treatment of chronic hepatitis C
por: Naylor, Paul H, et al.
Publicado: (2017) -
Primary IgA nephropathy with nephrotic-range proteinuria in Chinese children
por: Zhao, Jing-Li, et al.
Publicado: (2021) -
IgA Deficiency and Membranoproliferative Glomerulonephritis: A Case Report
por: Pezzutto, Alessandro, et al.
Publicado: (2021) -
Clinicopathologic Characteristics of IgA Nephropathy with Steroid-responsive Nephrotic Syndrome
por: Kim, Sun Moon, et al.
Publicado: (2009)